Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 11, 1997, Pages 5843-5847

  Danen Van Oorschot, A A A M ^a   Fischer, D F ^b   Grimbergen, J M ^c   Klein, B ^a   Zhuang, S M ^a,d   Falkenburg, J H F ^e   Backendorf, C ^b   Quax, P H A ^c   Van Der Eb, A J ^a   Noteborn, M H M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c TNO   (Netherlands)

^d LINKÖPING UNIVERSITY   (Sweden)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antitumor agent; Programmed cell death; Tumor cells

Indexed keywords

VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CIRCOVIRIDAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CAPSID; CAPSID PROTEINS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHICKEN ANEMIA VIRUS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; RECOMBINANT PROTEINS; SIMIAN VIRUS 40; SKIN; SKIN PHYSIOLOGY; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

CHICKEN ANEMIA VIRUS; CIRCOVIRIDAE; GALLUS GALLUS;

EID: 12644313241     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.11.5843     Document Type: Article

References (49)

1. Earnshaw, W. C. (1995) Curr. Opin. Cell Biol. 7, 337-343.
2. Wyllie, A. H., Kerr, J. F. R. & Currie, A. R. (1980) Int. Rev. Cytol. 68, 251-306.
3. Arends, M. J. & Wyllie, A. H. (1991) Int. Rev. Exp. Pathol. 32, 223-254.
4. Roy, C. (1992) Exp. Cell Res. 200, 416-424.
5. Wyllie, A. H. (1995) Curr. Opin. Genet. Dev. 5, 97-104.
6. White, E. (1996) Genes Dev. 10, 1-15.
7. Kerr, J. F. R., Winterford, C. M. & Harmon, B. V. (1994) Cancer 73, 2013-2026.
8. Thompson, C. B. (1995) Science 267, 1456-1462.
9. Bellamy, C. O. C., Malcomson, R. D. G., Harrison, D. J. & Wyllie, A. H. (1995) Semin. Cancer Biol. 6, 3-16.
10. Steller, H. (1995) Science 267, 1445-1449.
11. Kaufman, S. H. (1989) Cancer Res. 49, 5870-5879.
12. Warters, R. L. (1992) Cancer Res. 52, 883-890.
13. McDonell, T. J., Meyn, R. E. & Robertson, L. E. (1995) Semin. Cancer Biol. 6, 53-60.
14. Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. (1993) Cell 74, 957-967.
15. Fisher, D. E. (1994) Cell 78, 539-542.
16. Hooper, M. L. (1994) J. Cell Sci. Suppl. 18, 13-17.
17. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E. & Jacks, T. (1994) Science 266, 807-810.
18. Smith, M. L. & Fornace, A. J., Jr. (1995) Curr. Opin. Onc. 7, 69-75.
19. Hockenberry, D. M. (1994) J. Cell Sci. Suppl. 18, 51-55.
20. Wyllie, A. H. (1992) Cancer Metastasis Rev. 11, 95-103.
21. Sachs, L. & Lotem, J. (1993) Blood 82, 15-21.
22. Dive, C. & Wyllie, A. H. (1993) in Frontiers in Pharmacology: Cancer Chemotherapy, eds. Hickman, J. A. & Tritton, T. T. (Blackwell, Oxford), pp. 21-56.
23. Noteborn, M. H. M., De Boer, G. F., Van Roozelaar, D. J., Karreman, C., Kranenburg, O., Vos, J. G., Jeurissen, S. H. M., Hoeben, R. C., Zantema, A., Koch, G., Van Ormondt, H. & Van der Eb, A. J. (1991) J. Virol. 65, 3131-3139.
24. Noteborn, M. H. M., Todd, D., Verschueren, C. A. J., De Gauw, H. W. F. M., Curran, W. L., Veldkamp, S., Douglas, A. J., McNulty, M. S., Van der Eb, A. J. & Koch, G. (1994) J. Virol. 68, 346-351.
25. Noteborn, M. H. M. & Koch, G. (1995) Avion Pathol. 24, 11-31.
26. Zhuang, S.-M., Shvarts, A., Van Ormondt, H., Jochemsen, A. G., Van der Eb, A. J. & Noteborn, M. H. M. (1995) Cancer Res. 55, 486-489.
27. Zhuang, S.-M., Landegent, J. E., Verschueren, C. A. J., Falkenburg, J. H. F., Van Ormondt, H., Van der Eb, A. J. & Noteborn, M. H. M. (1995) Leukemia 9, S118-S120.
28. Zhuang, S.-M., Shvarts, A., Jochemsen, A. G., Van Oorschot, A. A. A. M., Van der Eb, A. J. & Noteborn, M. H. M. (1995) Carcinogenesis 16, 2939-2944.
29. Marijt, W. A., Veenhof, W. F., Brand, A., Goulmy, E., Fibbe, W. E., Willemze, R., Van Rood, J. J. & Falkenburg, J. H. (1991) J. Exp. Med. 173, 101-109.
30. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. (1973) J. Clin. Invest. 52, 2745-2756.
31. Rheinwald, J. G. & Green, H. (1975) Cell 6, 331-343.
32. Ponec, M., Kempenaar, J. A. & De Kloet, E. R. (1981) J. Invest. Dermatol. 76, 211-214.
33. Klein, B., Pastink. A., Odijk, H., Westerveld, A. & Van der Eb, A. J. (1990) Exp. Cell Res. 191, 256-262.
34. Weissman, B. E. & Stanbridge, E. J. (1983) Cytogenet. Cell Genet. 35, 263-268.
35. Rheinwald, J. G. & Beckett, M. A. (1981) Cancer Res. 41, 1657-1663.
36. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N. E. (1988) J. Cell Biol. 106, 761-771.
37. Taylor-Papadimitriou, J., Purkis, P., Lane, E. B., McKay, I. A. & Chang, S. E. (1982) Cell Differ. 11, 169-180.
38. Van der Eb, A. J. & Graham, F. L. (1980) Methods Enzymol. 65, 826-839.
39. Fischer, D. F., Gibbs, S., Van De Putte, P. & Backendorf, C. (1996) Mol. Cell. Biol. 16, 5365-5374.
40. Van den Heuvel, S. J. L., Van Laar, T., Kast, W. M., Melief, C. J., Zantema, A. & Van der Eb, A. J. (1990) EMBOJ. 9, 2621-2629.
41. Telford, W. G., King, L. E. & Fraker, P. J. (1992) Cytometry 13, 137-143.
42. Menke, A. L., Shvarts, A., Riteco, N., Van Ham, R. C. A., Van der Eb, A. J. & Jochemsen, A. G. (1997) Cancer Res. 57, in press.
43. Hill, R. P. & Tannock, I. F. (1992) in The Basic Science of Oncology, eds. Tannock, I. F. & Hill, R. P. (McGraw-Hill, New York), pp. 256-291.
44. Vanacker, J.-M. & Rommelaere, J. (1995) Semin. Virol. 6, 291-297.
45. Csermely, P., Schnaider, T. & Szanto, I. (1995) Biochim. Biophys. Acta 1241, 425-451.
46. Wen, W., Meinkoth, J. L., Tsien, R. Y. & Taylor, S. S. (1995) Cell 82, 463-473.
47. Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Lührmann, R. (1995) Cell 82, 475-483.
48. Gerace, L. (1995) Cell 82, 341-344.
49. Kyprianou, N. & Isaacs, J. T. (1989) Endocrinology 122, 522-532.